- Capital Cube•10 months ago
Biosino Bio-Technology & Science, Inc. relative valuation is OVERVALUED and it has a fundamental analysis score of 22.Our analysis is based on comparing Biosino Bio-Technology & Science, Inc. with the following peers – Sino Biopharmaceutical Limited, Essex Bio-Technology Limited, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Class H and Nanjing Sinolife United Co., Ltd. Class H […] (Read more...) The post Biosino Bio-Technology & Science, Inc.: Leading performance but fundamentals not looking strong? appeared first on CapitalCube.
We're sorry this is all we were able to find about this topic.
8247.HK : Summary for BIOSINO BIO-TEC - Yahoo Finance
BIOSINO BIO-TEC (8247.HK)
HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
|Day's Range||2.36 - 2.36|
|52 Week Range||2.30 - 4.13|
|PE Ratio (TTM)||31.52|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|